reserpine has been researched along with Basal Ganglia Diseases in 29 studies
Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
reserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Here we used the animal models of extrapyramidal disorders cited above, which were performed in two distinct experiments: orofacial dyskinesia (OD)/catalepsy induced by acute reserpine and subchronic haloperidol after (experiment 1) and before (experiment 2) oral treatment with pecan shell aqueous extract (AE), a natural and promissory antioxidant." | 1.37 | Comparative study between two animal models of extrapyramidal movement disorders: prevention and reversion by pecan nut shell aqueous extract. ( Barcelos, RC; Benvegnú, DM; Boufleur, N; Bürger, ME; Dias, VT; Dolci, GS; Pase, CS; Reckziegel, P; Segat, HJ; Trevizol, F, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (93.10) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trevizol, F | 1 |
| Benvegnú, DM | 1 |
| Barcelos, RC | 1 |
| Pase, CS | 1 |
| Segat, HJ | 1 |
| Dias, VT | 1 |
| Dolci, GS | 1 |
| Boufleur, N | 1 |
| Reckziegel, P | 1 |
| Bürger, ME | 1 |
| Veselinović, T | 1 |
| Schorn, H | 1 |
| Vernaleken, I | 1 |
| Schiffl, K | 1 |
| Hiemke, C | 1 |
| Zernig, G | 1 |
| Gur, R | 1 |
| Gründer, G | 1 |
| THIEBAUX, R | 1 |
| GERARDIN, JR | 1 |
| ROUSSEAU, G | 1 |
| STECK, H | 3 |
| BOURGUIGNON, A | 3 |
| DELAY, J | 2 |
| DENIKER, P | 2 |
| LEMPERIERE, T | 2 |
| RIVOLTA, A | 1 |
| GAMNA, G | 1 |
| BARUCCI, M | 1 |
| FREYHAN, FA | 1 |
| VORISEK, V | 1 |
| DEREUX, JB | 1 |
| DUC, M | 1 |
| ANTONOV, L | 1 |
| RICHMAN, A | 1 |
| TYHURST, JS | 1 |
| Risch, SC | 1 |
| Groom, GP | 1 |
| Janowsky, DS | 1 |
| Torrini, M | 1 |
| Masini, E | 1 |
| Ledda, F | 1 |
| Mannaioni, PF | 1 |
| Kuschinsky, K | 1 |
| Bourgeois, M | 1 |
| Stimmel, GL | 1 |
| Van Woert, MH | 1 |
| Sethy, VH | 1 |
| Ambani, LM | 1 |
| Carlsson, A | 1 |
| Andén, NE | 2 |
| Steg, G | 1 |
| Chase, TN | 1 |
| Omori, K | 1 |
| Orima, H | 1 |
| Kojima, T | 1 |
| Takahira, H | 1 |
| Hornykiewicz, O | 1 |
| Villeneuve, A | 1 |
| Julou, L | 1 |
5 reviews available for reserpine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Interfaces of psychopharmacology and cardiology--Part two.
Topics: Adrenergic alpha-Antagonists; Anti-Anxiety Agents; Antipsychotic Agents; Arrhythmias, Cardiac; Auton | 1981 |
[Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale].
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Benzamides; Butyrophenones; Child; Drug-Related Sid | 1981 |
Pathological aspects on Parkinson's syndrome.
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Central Nervous System; Chlorpromazine; Corpus Stria | 1972 |
Drug-induced extrapyramidal disorders.
Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopa | 1972 |
Dopamine and extrapyramidal motor function and dysfunction.
Topics: Animals; Apomorphine; Basal Ganglia Diseases; Butyrophenones; Caudate Nucleus; Dihydroxyphenylalanin | 1972 |
1 trial available for reserpine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine; Female; Haloperidol; Hu | 2011 |
23 other studies available for reserpine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Comparative study between two animal models of extrapyramidal movement disorders: prevention and reversion by pecan nut shell aqueous extract.
Topics: Animals; Basal Ganglia Diseases; Carya; Catalepsy; Disease Models, Animal; Haloperidol; Male; Moveme | 2011 |
[Accidents caused by reserpine; frequent occurrence of extrapyramidal signs].
Topics: Accidents; Antihypertensive Agents; Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Humans; | 1956 |
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Reserpine; Schizophr | 1956 |
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Reserpine; Schizophr | 1956 |
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Reserpine; Schizophr | 1956 |
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Reserpine; Schizophr | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Good results obtained with ACTH in extrapyramidal disorders caused by reserpine].
Topics: Adrenocorticotropic Hormone; Basal Ganglia Diseases; Extrapyramidal Tracts; Humans; Reserpine | 1957 |
[Interpretation of the extrapyramidal syndrome caused by reserpine].
Topics: Basal Ganglia Diseases; Extrapyramidal Tracts; Humans; Reserpine | 1957 |
[Psychomotility, extrapyramidal syndrome and mode of action of neuroleptic therapies; chlorpromazine, reserpine and prochlorperazine].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans | 1957 |
[Reserpine treatment of Huntington's chorea & other extrapyramidal syndromes].
Topics: Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Humans; Huntington Disease; Reserpine; Syndr | 1958 |
[Extrapyramidal syndromes induced by chlorpromazine and reserpine].
Topics: Basal Ganglia Diseases; Chlorpromazine; Extrapyramidal Tracts; Reserpine; Syndrome | 1960 |
[Extrapyramidal syndrome in the course of delirium tremens. Role of reserpine. Diagnostic and therapeutic problems].
Topics: Alcohol Withdrawal Delirium; Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Mental Disorder | 1959 |
[Role of central mediators in experimental production and drug therapy of some extrapyramidal disorders].
Topics: Basal Ganglia Diseases; Central Nervous System; Chlorpromazine; Monoamine Oxidase Inhibitors; Muscle | 1961 |
An extrapyramidal syndrome with reserpine.
Topics: Antihypertensive Agents; Basal Ganglia Diseases; Humans; Reserpine; Secologanin Tryptamine Alkaloids | 1955 |
[Extrapyramidal and diencephalic syndrome in the course of largactil and serpasil treatments].
Topics: Antihypertensive Agents; Basal Ganglia Diseases; Chlorpromazine; Diencephalon; Disease; Extrapyramid | 1954 |
[Cellular effect of neuroleptics].
Topics: Adenylyl Cyclases; Basal Ganglia Diseases; Biological Transport, Active; Catecholamines; Chlorpromaz | 1975 |
[Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Diagnosis, Differential; Dyskine | 1977 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloper | 1976 |
Effect of phenothiazines on central cholinergic activity.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Brain Chemistry; Chlorp | 1974 |
Antipsychotic drugs and catecholamine synapses.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Catecholamines; Chlorprom | 1974 |
Antipsychotic drugs and catecholamine synapses. Summary of the session.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Brain; Butyrophenones; Catecholamines; Corpus Striatum | 1974 |
[Pharmacological studies on 5-hydroxy-L-tryptophan (L-5HTP). 1. Influence of L-5HTP on the central nervous system].
Topics: 5-Hydroxytryptophan; Analgesics; Anesthesia, General; Animals; Anticonvulsants; Basal Ganglia Diseas | 1973 |
[Neuroleptics: functional and biochemical effects].
Topics: Animals; Basal Ganglia Diseases; Blood Pressure; Brain Chemistry; Cats; Chlorpromazine; Drug Interac | 1972 |
The rabbit syndrome. A peculiar extrapyramidal reaction.
Topics: Aged; Anxiety; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Fatigue; Female; Humans; Male; M | 1972 |
On the interaction between neuroleptics and antiparkinson drugs.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; C | 1970 |